XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).

HONG KONG,Feb. 14,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China Natio

Champion of the HERO ESPORTS Asian Champions League Honor of Kings tournament will secure a spot at the Esports World Cup

BEIJING,Feb. 11,2025--In a world where AI,digitalization,and geopolitical shifts are reshaping business strategy,companies must position themselves to scale effectively and adapt to changes.Cheung Kon

VANCOUVER,BC,Feb. 11,2025-- Wondershare,a pioneer in digital creativity and productivity software,has launched Repairit 6.5,the latest iteration of its flagship data repair tool. Trusted by users wor

JAKARTA,Indonesia,Feb. 12,2025-- PT Telekomunikasi Indonesia International (Telin) announced Bifrost Cable System has successfully landed in Manado. Bifrost,submarine cable system connects Singapore t

Partnership taps real-world data to accelerate clinical trials,research,and drug development in Japan.

HONG KONG,Feb. 10,2025-- Law Wai-Sum (A.K.A. J Law) has made history as the first Hong Kong participant to win the prestigious US Investing Championship. Competing in the $1 million Money Manager Veri

- The new Global X AI Infrastructure ETF (3401)brings Mirae Asset\'s AI-themed lineup to six products,offering both active and passive strategies for comprehensive investment solutions.

HELSINKI,Feb. 7,2025-- In 2025,one Finland\'s most cherished cultural icons,the Moomins,celebrate their 80th anniversary. Helsinki,home to their beloved creator Tove Jansson,honors this milestone with